TR200102604T2 - Işığa duyarlı törapötik sistemler ile bunlara ait bileşenlerin tatbiki ve/veya saklanması sırasında stabilitelerinin artırılmasına ilişkin yöntem - Google Patents

Işığa duyarlı törapötik sistemler ile bunlara ait bileşenlerin tatbiki ve/veya saklanması sırasında stabilitelerinin artırılmasına ilişkin yöntem

Info

Publication number
TR200102604T2
TR200102604T2 TR2001/02604T TR200102604T TR200102604T2 TR 200102604 T2 TR200102604 T2 TR 200102604T2 TR 2001/02604 T TR2001/02604 T TR 2001/02604T TR 200102604 T TR200102604 T TR 200102604T TR 200102604 T2 TR200102604 T2 TR 200102604T2
Authority
TR
Turkey
Prior art keywords
storage
stability
therapeutic systems
increasing
components during
Prior art date
Application number
TR2001/02604T
Other languages
English (en)
Inventor
Berthold Achim
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200102604T2 publication Critical patent/TR200102604T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Elektromanyetik dalgalari soguran ya da yansitan isik stabilite ajanlarini kullanmak suretiyle isiga duyarli törapötik sistemler ile erken ve yardimci maddeler gibi bunlara ait bilesenlerin tatbiki ve/veya saklanmasi sirasinda stabilitelerinin artirilmasina iliskin yöntem, ki bu süreç absorbsiyon veya yansima spektrumu, dalgaboyunun isiga duyarli materyalin ya da buna ait bilesenin kararsizligindan sorumlu olan araligini içine alan absorbsiyon ve refleksiyon ajanlarinin kullanilmasi ile karakterizedir.
TR2001/02604T 1999-03-20 2000-03-08 Işığa duyarlı törapötik sistemler ile bunlara ait bileşenlerin tatbiki ve/veya saklanması sırasında stabilitelerinin artırılmasına ilişkin yöntem TR200102604T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19912623A DE19912623A1 (de) 1999-03-20 1999-03-20 Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile

Publications (1)

Publication Number Publication Date
TR200102604T2 true TR200102604T2 (tr) 2002-01-21

Family

ID=7901787

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02604T TR200102604T2 (tr) 1999-03-20 2000-03-08 Işığa duyarlı törapötik sistemler ile bunlara ait bileşenlerin tatbiki ve/veya saklanması sırasında stabilitelerinin artırılmasına ilişkin yöntem

Country Status (13)

Country Link
EP (1) EP1162957A1 (tr)
JP (1) JP2002539238A (tr)
KR (1) KR20010114231A (tr)
CN (1) CN1343117A (tr)
AR (1) AR023100A1 (tr)
AU (1) AU771819B2 (tr)
BR (1) BR0010516A (tr)
CA (1) CA2366859A1 (tr)
DE (1) DE19912623A1 (tr)
HK (1) HK1039277A1 (tr)
TR (1) TR200102604T2 (tr)
WO (1) WO2000056289A1 (tr)
ZA (1) ZA200107523B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
MEP14008A (en) 2003-02-21 2010-06-10 Bayer Schering Pharma Ag Uv stable transdermal therapeutic plaster
DE10317692A1 (de) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
DE602005018387D1 (de) * 2004-10-06 2010-01-28 Eisai R&D Man Co Ltd Medizinische zusammensetzung, verfahren zu ihrer hdihydropyridin-verbindung in einer medizinischen zusammensetzung
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102010050242A1 (de) 2010-10-30 2012-05-03 Schott Ag Wirkstoffverpackung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832821A (ja) * 1981-08-20 1983-02-25 Sumitomo Bakelite Co Ltd 光分解性医薬品を収納した遮光性包装物
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
JPH03145421A (ja) * 1989-10-31 1991-06-20 Zeria Pharmaceut Co Ltd 安定な点眼剤
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
JPH07204251A (ja) * 1993-10-15 1995-08-08 Dai Ichi Seiyaku Co Ltd キノロン系抗菌薬製剤

Also Published As

Publication number Publication date
WO2000056289A1 (de) 2000-09-28
JP2002539238A (ja) 2002-11-19
BR0010516A (pt) 2003-07-22
AU771819B2 (en) 2004-04-01
CA2366859A1 (en) 2000-09-28
AR023100A1 (es) 2002-09-04
CN1343117A (zh) 2002-04-03
HK1039277A1 (zh) 2002-04-19
AU3809100A (en) 2000-10-09
EP1162957A1 (de) 2001-12-19
ZA200107523B (en) 2002-11-27
KR20010114231A (ko) 2001-12-31
DE19912623A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
DE69815003D1 (de) Stabilisierte pharmazeutische Zusammensetzung
WO2004086577A3 (en) Improvements in and relating to vertical-cavity semiconductor optical devices
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
BR0305316A (pt) Dobradiça
DE69130709D1 (de) Gezielte immunostimulierung mit bispezifischen stoffen
DK0934937T3 (da) Azolderivater som superoxidradikalinhibitor
DE69721153D1 (de) Verpackung eines optoelektronischen Bauelements
SE9301539L (sv) Icke-migrerande 1-hydrokarbyloxi-2,2,6,6-tetrametylpiperidin- 1,3,5-triazinderivat som polymerstabilisator
DK1005313T3 (da) En absorberende artikel sådan som en ble eller en inkontinensbeskyttelse
EG21087A (en) Foams made from high internal phase emulsions useful as absorbent members from catamenial pads
DK0639186T3 (da) Taxolderivater
DK0629616T3 (da) Optisk aktive 2-imidazolin-5-on-derivater som fungicider
ATE233539T1 (de) Schaumförmige lichtzubereitungen mit einem gehalt an wasserlöslichen lichtschutzsubstanzen und grenzflächenaktiven substanzen
AR012673A1 (es) Compuesto de ester de etilenglicol de monohidrobenzoporfirina utiles para terapia fotodinamica, composiciones farmaceuticas y uso de los mismos.
ZA96134B (en) Foams made from high internal phase emulsions useful as absorbent members for catamenial pads
EP0667700A3 (en) Method and device for echo cancellation using the "fast projection scheme".
DE69724634D1 (de) Faltbare schutzverpackung
DE69908311D1 (de) Mehrfachecke kirkpatrick-baez optische strahlbehandlungsanordnung
DE69115033D1 (de) Wellenleiter-laser.
FR2661036B1 (fr) Dispositif enrobe.
TR199900195T2 (tr) Sitmaya karsi asi kompozisyonu.
DE69220664D1 (de) Kationische polysaccharide
HK1039277A1 (zh) 改善庫存及/或用過的各種光敏治療系統及其成分的穩定性的方法
EP1180717A3 (en) Optical harmonic generator
EA200000092A1 (ru) Противоаллергические средства